Although our previous in vitro study showed C18:2 mediates CPT1a induction, the details of how the CPT genes are regulated in CD4+ T cells in the context of NAFLD and their potential role in HCC development are still unknown8. The gene discussed is CPT1A; the disease is metabolic dysfunction-associated steatotic liver disease.